| Post |
| Pre |
| LA |
|---|
| 2.3 |
| 1.1 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 26.1 | 14.5 | 37.2 | 6.9 | 3.4 | 3.1 | - | - | - | - | 91.1 |
| 5.4 | 0.5 | 1.2 | 4.7 | 14.3 | 14.0 | - | - | - | - | 40.1 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 14,784 | 86.1% | -1.37 | 5,716 | 81.8% |
| Optic-unspecified(L) | 2,254 | 13.1% | -0.90 | 1,212 | 17.3% |
| LA(L) | 134 | 0.8% | -1.11 | 62 | 0.9% |
| upstream partner | # | NT | conns R7_unclear | % In | CV |
|---|---|---|---|---|---|
| Dm9 (L) | 97 | Glu | 48.0 | 58.2% | 0.9 |
| R8_unclear | 163 | HA | 29.1 | 35.2% | 0.3 |
| C2 (L) | 113 | GABA | 1.9 | 2.3% | 0.7 |
| Dm8b (L) | 72 | Glu | 0.7 | 0.9% | 0.6 |
| R8_unclear (L) | 1 | HA | 0.3 | 0.4% | 0.0 |
| L3 (L) | 39 | ACh | 0.3 | 0.3% | 0.5 |
| Mi4 (L) | 4 | GABA | 0.2 | 0.3% | 1.6 |
| Tm5Y (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| Dm4 (L) | 2 | Glu | 0.2 | 0.2% | 0.7 |
| MeTu3c (L) | 16 | ACh | 0.2 | 0.2% | 0.8 |
| Dm11 (L) | 16 | Glu | 0.2 | 0.2% | 0.6 |
| C3 (L) | 22 | GABA | 0.2 | 0.2% | 0.3 |
| Mi15 (L) | 17 | ACh | 0.1 | 0.2% | 0.6 |
| Tm2 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| L1 (L) | 16 | Glu | 0.1 | 0.1% | 0.3 |
| Mi9 (L) | 2 | Glu | 0.1 | 0.1% | 0.9 |
| Mi1 (L) | 8 | ACh | 0.1 | 0.1% | 0.7 |
| Dm8a (L) | 6 | Glu | 0.0 | 0.1% | 0.6 |
| Dm2 (L) | 7 | ACh | 0.0 | 0.1% | 0.0 |
| T1 (L) | 2 | HA | 0.0 | 0.0% | 0.3 |
| R7_unclear | 3 | HA | 0.0 | 0.0% | 0.4 |
| L5 (L) | 4 | ACh | 0.0 | 0.0% | 0.3 |
| Cm11c (L) | 6 | ACh | 0.0 | 0.0% | 0.0 |
| L4 (L) | 2 | ACh | 0.0 | 0.0% | 0.5 |
| Dm10 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| R7y | 1 | HA | 0.0 | 0.0% | 0.0 |
| TmY18 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MeTu3b (L) | 3 | ACh | 0.0 | 0.0% | 0.0 |
| L2 (L) | 3 | ACh | 0.0 | 0.0% | 0.0 |
| Tm6 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Cm4 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Tm29 (L) | 2 | Glu | 0.0 | 0.0% | 0.0 |
| Cm11d (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Dm20 (L) | 2 | Glu | 0.0 | 0.0% | 0.0 |
| ME_LO_unclear (L) | 1 | unc | 0.0 | 0.0% | 0.0 |
| Cm8 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| R1-R6 | 1 | HA | 0.0 | 0.0% | 0.0 |
| Dm1 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Mi19 (L) | 1 | unc | 0.0 | 0.0% | 0.0 |
| Dm14 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Cm27 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Cm11b (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MeLo1 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm5c (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Dm-DRA2 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Dm13 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| OA-AL2i3 (L) | 1 | OA | 0.0 | 0.0% | 0.0 |
| Cm11a (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| aMe30 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Cm9 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| downstream partner | # | NT | conns R7_unclear | % Out | CV |
|---|---|---|---|---|---|
| Dm8b (L) | 201 | Glu | 38.6 | 28.7% | 0.7 |
| MeTu3c (L) | 67 | ACh | 16.4 | 12.2% | 0.6 |
| Dm9 (L) | 92 | Glu | 14.6 | 10.9% | 0.9 |
| R8_unclear | 155 | HA | 10.9 | 8.1% | 0.4 |
| Dm8a (L) | 170 | Glu | 9.9 | 7.4% | 0.9 |
| Tm5b (L) | 126 | ACh | 8.3 | 6.2% | 0.7 |
| L3 (L) | 170 | ACh | 6.9 | 5.2% | 0.5 |
| Dm11 (L) | 48 | Glu | 4.3 | 3.2% | 0.8 |
| MeTu3b (L) | 33 | ACh | 3.9 | 2.9% | 0.9 |
| Dm2 (L) | 155 | ACh | 3.8 | 2.8% | 0.7 |
| Tm5a (L) | 57 | ACh | 2.0 | 1.5% | 0.9 |
| Tm20 (L) | 78 | ACh | 1.8 | 1.3% | 0.9 |
| Mi15 (L) | 79 | ACh | 1.3 | 1.0% | 0.7 |
| Tm29 (L) | 58 | Glu | 1.2 | 0.9% | 0.9 |
| Cm2 (L) | 49 | ACh | 1.1 | 0.8% | 0.8 |
| Mi9 (L) | 77 | Glu | 1.0 | 0.7% | 1.0 |
| aMe12 (L) | 4 | ACh | 0.8 | 0.6% | 0.1 |
| T2 (L) | 45 | ACh | 0.6 | 0.5% | 0.6 |
| L1 (L) | 60 | Glu | 0.6 | 0.5% | 1.0 |
| Tm5c (L) | 37 | Glu | 0.6 | 0.4% | 0.8 |
| Cm11d (L) | 9 | ACh | 0.5 | 0.4% | 0.7 |
| MeTu3a (L) | 12 | ACh | 0.5 | 0.4% | 0.7 |
| TmY18 (L) | 31 | ACh | 0.4 | 0.3% | 1.2 |
| C2 (L) | 36 | GABA | 0.3 | 0.2% | 0.4 |
| L2 (L) | 32 | ACh | 0.2 | 0.2% | 0.4 |
| T1 (L) | 27 | HA | 0.2 | 0.2% | 0.5 |
| Dm-DRA1 (L) | 3 | Glu | 0.2 | 0.1% | 0.4 |
| Tm12 (L) | 19 | ACh | 0.2 | 0.1% | 0.6 |
| C3 (L) | 18 | GABA | 0.2 | 0.1% | 0.7 |
| Cm1 (L) | 18 | ACh | 0.2 | 0.1% | 0.5 |
| MeVPMe3 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Dm4 (L) | 17 | Glu | 0.2 | 0.1% | 0.6 |
| Dm13 (L) | 2 | GABA | 0.1 | 0.1% | 0.9 |
| MeVP43 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeTu1 (L) | 7 | ACh | 0.1 | 0.1% | 0.5 |
| aMe5 (L) | 11 | ACh | 0.1 | 0.1% | 0.6 |
| Mi1 (L) | 13 | ACh | 0.1 | 0.1% | 0.7 |
| Dm-DRA2 (L) | 4 | Glu | 0.1 | 0.1% | 1.0 |
| Cm27 (L) | 4 | Glu | 0.1 | 0.1% | 0.6 |
| Mi4 (L) | 12 | GABA | 0.1 | 0.1% | 0.5 |
| L5 (L) | 15 | ACh | 0.1 | 0.1% | 0.3 |
| Cm4 (L) | 11 | Glu | 0.1 | 0.1% | 0.5 |
| R8_unclear (L) | 1 | HA | 0.1 | 0.1% | 0.0 |
| Cm21 (L) | 4 | GABA | 0.1 | 0.1% | 0.5 |
| Cm9 (L) | 3 | Glu | 0.1 | 0.1% | 1.1 |
| aMe6c (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeLo1 (L) | 6 | ACh | 0.1 | 0.1% | 0.8 |
| MeVP63 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| aMe3 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm39 (L) | 5 | ACh | 0.1 | 0.0% | 0.8 |
| Cm11b (L) | 4 | ACh | 0.0 | 0.0% | 0.9 |
| MeVP15 (L) | 2 | ACh | 0.0 | 0.0% | 0.4 |
| Tm5Y (L) | 2 | ACh | 0.0 | 0.0% | 0.7 |
| R7_unclear | 3 | HA | 0.0 | 0.0% | 0.4 |
| Dm1 (L) | 3 | Glu | 0.0 | 0.0% | 0.0 |
| MeVPLp1 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| L4 (L) | 6 | ACh | 0.0 | 0.0% | 0.0 |
| MeVPLo2 (L) | 5 | ACh | 0.0 | 0.0% | 0.3 |
| OA-AL2i3 (L) | 2 | OA | 0.0 | 0.0% | 0.2 |
| Cm5 (L) | 4 | GABA | 0.0 | 0.0% | 0.3 |
| MeVPMe12 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Cm26 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| aMe30 (L) | 2 | Glu | 0.0 | 0.0% | 0.3 |
| Cm17 (L) | 2 | GABA | 0.0 | 0.0% | 0.3 |
| MeVPMe12 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Cm11a (L) | 2 | ACh | 0.0 | 0.0% | 0.3 |
| Tm37 (L) | 3 | Glu | 0.0 | 0.0% | 0.0 |
| Mi10 (L) | 3 | ACh | 0.0 | 0.0% | 0.0 |
| Lawf2 (L) | 3 | ACh | 0.0 | 0.0% | 0.0 |
| Tm9 (L) | 3 | ACh | 0.0 | 0.0% | 0.0 |
| Cm8 (L) | 3 | GABA | 0.0 | 0.0% | 0.0 |
| Dm10 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Tm2 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| TmY5a (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| MeTu2a (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm36 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| TmY3 (L) | 2 | ACh | 0.0 | 0.0% | 0.0 |
| Tm3 (L) | 2 | ACh | 0.0 | 0.0% | 0.0 |
| Dm3b (L) | 2 | Glu | 0.0 | 0.0% | 0.0 |
| Lawf1 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Cm19 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Tm6 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Mi18 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| MeLo2 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| T2a (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| aMe17b (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Dm3a (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| Tm4 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Mi2 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm31 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Dm6 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| R7d | 1 | HA | 0.0 | 0.0% | 0.0 |